Pre-operative combined 5-FU, low dose leucovorin, and sequential radiation therapy for unresectable recta cancer Academic Article Article uri icon

Overview

MeSH Major

  • Adenocarcinoma
  • Biomarkers, Tumor
  • Genomic Instability
  • Pancreatic Neoplasms
  • Precision Medicine

abstract

  • Since adequate doses of 5-FU to treat systemic disease could not be delivered until at least 3 months (cycle 3) following the start of therapy, we do not recommend that this 5-FU, low dose LV, and sequential radiation therapy regimen be used as presently designed. However, given the 91% resectability rate we remain encouraged with this approach.

publication date

  • April 2, 1993

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1016/0360-3016(93)90311-I

PubMed ID

  • 8478232

Additional Document Info

start page

  • 821

end page

  • 7

volume

  • 25

number

  • 5